.png){kind=icon}
Return
Prediabetes
.png){kind=icon}
PRE
AI
DOI：10.1038/s41572-025-00635-0.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Prediabetes or intermediate hyperglycaemia represents a preliminary stage in the development of type 2 diabetes mellitus (T2DM). In addition to an increased likelihood of developing T2DM, individuals with prediabetes have an elevated risk of various vascular and non-vascular complications. No consensus has been achieved on the ideal screening strategy for prediabetes, with fasting plasma glucose concentration, glycated haemoglobin (HbA1c) and the oral glucose tolerance test being the most frequently measured parameters. The two major phenotypes of prediabetes, that is, impaired fasting glucose and impaired glucose tolerance, may represent different pathophysiologies with varying natural history, risk of adverse outcomes and responsiveness to treatment. Most of the evidence for managing prediabetes focuses on lifestyle modification with or without medications in individuals with overweight or obesity and impaired glucose tolerance. Whether these interventions are beneficial in individuals with impaired fasting glucose and those of normal body weight is unclear, as is the cost-effectiveness and sustainability of pharmacotherapy for treating prediabetes. Large-scale national T2DM prevention programmes are currently under way to assess whether the benefits of interventions for prediabetes can be translated to the community setting. Prediabetes refers to individuals with blood glucose levels above the normal levels but below the thresholds for a diabetes mellitus diagnosis. In this Primer, Mohan and colleagues discuss the increasing prevalence of prediabetes, its pathophysiology and diagnosis as well as the importance of early intervention to improve adverse outcomes in patients.
Journal
N
IF:
60.6
Papers:
651
Citations:
3.8W
Organization
Cited Papers
ShareSaveShareSaveNon-pharmacological interventions for the prevention of type 2 diabetes in low-income and middle-income countries: a systematic review of randomised controlled trials.png)
BMJ Open
OAAI
BMJ OpenIF0
OAAIShareSaveShareSaveTrends and disparities in diabetes and prediabetes among adults in the United States, 1999-2018PUBLIC HEALTH
OAAI
PUBLIC HEALTHIF3.2
OAAIShareSaveSustained reduction in the incidence of type 2 diabetes by lifestyle intervention:: follow-up of the Finnish Diabetes Prevention StudyLANCET
LANCETIF88.5
PREAI
ShareSaveShareSaveAcarbose for prevention of type 2 diabetes mellitus: the STOPNIDDM randomised trialLANCET
LANCETIF88.5
PREAI
ShareSave
View more